Table 2. Multivariate analyses and tests for equality of ORs for fasting and non-fasting hypertriglyceridemiaa .
| Characteristics | Fasting hypertriglyceridemia | Non-fasting hypertriglyceridemia | P value for OR equality | |||||
|---|---|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | |||
| Males | 0.88 | 0.62–1.24 | 0.410 | 1.20 | 0.92–1.57 | 0.198 | 0.052 | |
| Age, 10 yr | 0.98 | 0.96–0.98 | 0.001 | 0.98 | 0.98–0.99 | 0.001 | 0.388 | |
| BMI, 1 kg/m2 | 1.11 | 1.07–1.13 | < 0.001 | 1.11 | 1.07–1.14 | < 0.001 | 0.749 | |
| SBP, 10 mmHg | 1.08 | 1.03–1.14 | 0.003 | 1.06 | 1.02–1.11 | 0.003 | 0.682 | |
| Family history of premature CHD | 1.42 | 0.75–2.80 | 0.288 | 1.98 | 1.11–3.53 | 0.021 | 0.371 | |
| Family history of stroke | 0.368 | |||||||
| None | Reference | Reference | ||||||
| ≥ 60 yr | 1.22 | 0.88–1.90 | 0.210 | 1.34 | 0.99–1.82 | 0.062 | ||
| < 60 yr | 0.89 | 0.52–1.58 | 0.688 | 1.34 | 0.81–2.23 | 0.251 | ||
| Medical history | ||||||||
| Stroke or TIA | 0.82 | 0.58–1.18 | 0.335 | 0.67 | 0.50–0.90 | 0.012 | 0.218 | |
| CHD | 1.00 | 0.58–1.75 | 0.998 | 0.66 | 0.42–1.03 | 0.076 | 0.188 | |
| Hypertension | 1.08 | 0.82–1.42 | 0.582 | 0.96 | 0.75–1.23 | 0.718 | 0.361 | |
| Diabetes | 1.68 | 1.30–2.35 | 0.003 | 1.71 | 1.37–2.14 | < 0.001 | 0.951 | |
| Hypercholesterolemia | 1.58 | 1.11–2.20 | 0.009 | 1.24 | 0.94–1.65 | 0.132 | 0.198 | |
| Atrial fibrillation | 0.98 | 0.54–1.84 | 0.962 | 0.75 | 0.51–1.11 | 0.162 | 0.359 | |
| Ever-smoking | 1.42 | 1.03–2.04 | 0.038 | 1.15 | 0.90–1.48 | 0.271 | 0.176 | |
| History of statin use | 0.68 | 0.42–1.01 | 0.058 | 0.75 | 0.54–1.06 | 0.101 | 0.498 | |
| Sampling interval time, min | 1.02 | 0.96–1.10 | 0.524 | 1.04 | 0.98–1.10 | 0.192 | 0.712 | |
OR = odds ratio, CI = confidence interval, BMI = body mass index, SBP = systolic blood pressure, CHD = coronary heart disease, TIA = transient ischemic attack.
aHypertriglyceridemia was defined as above 150 mg/dL for fasting triglycerides and above 200 mg/dL for non-fasting triglycerides.